DAPJON 10
DAPJON 10 contains Dapagliflozin 10mg, a sodium-glucose co-transporter 2 (SGLT2) inhibitor indicated for the management of Type 2 Diabetes Mellitus. It lowers blood glucose by promoting urinary glucose excretion and also has proven cardiovascular and renal protective benefits.
SGLT2 Inhibitor — Antidiabetic
Dapagliflozin selectively inhibits SGLT2, reducing renal glucose reabsorption and increasing urinary glucose excretion. This results in a reduction in both fasting and postprandial plasma glucose concentrations independent of insulin secretion.
science Molecular Profile
inventory_2 Packaging
public Distribution Reach
Cleared for logistics within:
Thermal Integrity
"Our cold-chain protocol ensures zero-fluctuation transport from laboratory to clinician."
Cold-Chain Requirements
Real-time Monitoring
Integrated Bluetooth temperature loggers in every shipping container provide minute-by-minute data.
Passive VIP Insulation
Vacuum Insulated Panels (VIP) maintain critical temperature stability for up to 144 hours.
Interested in DAPJON 10?
Submit an inquiry and our team will get back to you with availability and pricing.
Distribution Inquiry
